UPI Study › Courses › Business Ethics › Free lessons › Lesson 12.4 Free with a free account
How Advertising Is Regulated: Laws, Agencies, and Industry Self-Governance
Business Ethics · Chapter 12: Ethics in Advertising and MarketingSection 12.4 · lesson 72 of 10516 min · free with a free account
Free preview
Create a free account to keep watching
It takes a minute and costs nothing. Your free account unlocks all of Chapter 1 and 3 more lessons of Business Ethics.
Lesson complete
Earn the 3 college credits for Business Ethics
Enrolling adds a quiz after each lesson, the graded work and the official transcript. Recommended for credit by NCCRS.
Next lesson: Recurring Ethical Issues in Advertising: Deception, Manipulation, and Vulnerable Audiences →← The AMA’s Ethical Framework: Norms, Values, and Professional StandardsNext lesson: Recurring Ethical Issues in Advertising: Deception, Manipulation, and Vulnerable Audiences →
In this lesson
Laws, Agencies, and Industry Self-Governance.
- Apply the FTC’s deception, unfairness, and prior-substantiation standards.
- Distinguish all four source statements as measurable claims or subjective puffery.
- Explain private false-advertising litigation and plaintiff and remedy limits.
- Compare industry self-regulation with government action through the full supplement case.
Free study notes
Get this lesson's notes by email
The key points and 4 practice questions with answers, in your inbox. One email, free.
One email. Unsubscribe in one click.
Transcript
Everything said in the video, section by section (1,973 words). Read along, or search it.
Ethics in Advertising and Marketing
How Advertising Is Regulated
Advertising faces government enforcement, private lawsuits, and voluntary industry review, each with its role. FTC’s deception standard addresses misleading material meaning, assessed through a reasonable consumer in context. A related unfairness standard addresses substantial injury that consumers cannot reasonably avoid without countervailing benefits. Objective advertising claims also require an adequate evidence before dissemination, rather than after a challenge. We will compare four statements, distinguishing clinical and comparative promises from subjective advertising praise. The Lanham Act gives qualifying businesses a private civil route without waiting for government action. A competitor often sues, but direct competition is not an absolute prerequisite. The National Advertising Division offers voluntary substantiation review within BBB National Programs. Recommendations can prompt changes, and refusal can lead to referral for possible regulatory action. The diagram shows three independent routes operating concurrently or in different orders. Its supplement example follows a precise weight-loss promise through weak evidence, partial change, and referral. We will preserve every step while distinguishing investigations, recommendations, legal findings, and available remedies.
Separate Legal Standards
Deception Concerns Misleading Material Meaning; Unfairness Concerns Unjustified Consumer Injury
Section five of the FTC Act prohibits unfair or deceptive acts or practices in commerce. Deception involves a representation, omission, or practice likely to mislead a consumer acting reasonably in context. The meaning must affect conduct or decisions about the product or service materially. The source emphasizes purchasing decisions. FTC’s formulation also includes conduct, such as use. Reasonableness depends on circumstances, including the particular audience primarily addressed by the advertising practice. An omission can mislead when missing information changes the meaning the audience reasonably takes away. The standard concerns likely deception, rather than proof that every audience member was actually deceived. Unfairness separately tests substantial consumer injury, including injury the practice is likely to cause. Consumers must not reasonably be able to avoid that injury, and countervailing benefits must not outweigh it. Those benefits concern consumers or competition, rather than simply increasing the advertiser’s private revenue. Neither a disappointing purchase nor a troubling slogan, standing alone, proves the complete legal test. Analyze the particular message, circumstances, material meaning, and injury rather than merging these distinct standards.
Evidence Comes Before Dissemination
An Objective Claim Needs a Reasonable Basis Before the Advertiser Runs It
Prior substantiation requires a reasonable evidentiary basis for an objective claim before the advertiser makes it. An advertiser cannot publish first and treat a later request for evidence as the starting point. Objective assertions can be explicit in words or reasonably implied by the advertisement’s overall presentation. Evidence must support the communicated claim, not a weaker claim the advertiser privately intended. If advertising promises clinical proof, support must meet the level of evidence conveyed. Possessing a study does not establish that it adequately supports that promise. Its design, size, methods, population, and results matter when evaluating the actual claim being made. The source supplement case illustrates a study too weak to support a precise percentage benefit. A reasonable basis depends on the claim and product, rather than one universal research requirement. FTC can consider later evidence in limited discretionary ways when assessing enforcement or order scope. That discretion does not replace the legal requirement to possess adequate support before dissemination. The practical sequence is to identify the objective message, evaluate relevant evidence, and then decide publication. A complaint can expose an evidence problem, but does not create the substantiation duty.
Every Statement in the Claims Table
Precise Clinical and Comparative Claims Differ From Subjective Taste and Experience
The source compares four statements, distinguishing factual specificity from subjective advertising praise. The first promises that a product reduces cavities by forty percent in clinical trials. That measurable percentage is testable, and the clinical-trial wording also communicates a level of support. The advertiser therefore needs evidence adequate for both the promised benefit and the supporting-study claim. The second calls a coffee the best-tasting coffee in the world, illustrating subjective taste opinion. In that source example, no reasonable audience takes the praise as a precise factual measurement. The third says a formula lasts twice as long as the company’s previous formula. This verifiable comparison requires substantiation for the products and comparison communicated. The fourth promises you will love the way a car makes you feel. The source treats that vague personal experience as subjective, rather than a testable product representation. Puffery describes subjective or exaggerated praise that consumers would not reasonably understand as factual measurement. Context still matters: surrounding words or presentation could communicate a measurable promise requiring actual support. No real clinical trial, formula test, taste survey, or individual driving experience is supplied here.
Private Civil Litigation Under the Lanham Act
A Qualifying Business Can Sue Directly Without Waiting for FTC Enforcement
Government enforcement is not the only way a business can challenge false advertising harming its interests. The Lanham Act provides a private civil route in federal court, without requiring FTC involvement first. The source describes a competitor suing directly, a common illustration of commercial advertising injury. Its competitor-only wording is shorthand, however, rather than an absolute rule limiting every eligible plaintiff. In March twenty-fifth, twenty fourteen, the Supreme Court’s Lexmark decision rejected a categorical direct-competitor test. A plaintiff must allege commercial reputation or sales injury within the interests the statute protects. That injury must be proximately caused by alleged false advertising, rather than excessively remote harm. A disappointed consumer does not automatically have this commercial false-advertising cause of action. Qualifying as a plaintiff still does not establish every element of the underlying advertising claim. Possible remedies include an injunction stopping the challenged conduct and damages for proven harm. Defendant profits may also be recoverable in appropriate circumstances, governed by applicable law and equitable principles. Those remedies do not automatically follow from a complaint or labeling an advertisement false. Keep plaintiff eligibility, liability, and remedies separate when comparing litigation with government action.
Actual Source Figure and All Its Captions
One Claim Can Face Three Independent Channels, Concurrently or in Any Order
The actual source diagram begins with one questionable advertising claim and branches into three independent channels. Government enforcement is brought by FTC, which investigates and can pursue orders stopping unlawful advertising. Its source caption also mentions fines, but civil penalties require the applicable statutory conditions. A first deceptive advertisement does not invariably expose its advertiser to an automatic FTC fine. Private litigation is brought by a competitor in the source, or another qualifying commercial plaintiff. A Lanham Act lawsuit proceeds in federal court seeking damages or an injunction for relevant harm. Industry self-regulation provides a voluntary NAD review, recommending modification or discontinuation of the challenged claim. The source describes this route as an efficient alternative, rather than another court issuing legal orders. These three arrows are parallel options. They do not prescribe a compulsory chronological enforcement sequence. The figure explicitly says the same claim may face self-review, private litigation, and government scrutiny. Its caption allows simultaneous channels as well as challenges occurring in a different order. The supplement case next illustrates one possible escalation from self-review to an independent government investigation.
Industry Self-Governance
NAD Reviews Substantiation and Recommends Changes; FTC Makes Its Own Enforcement Decision
The National Advertising Division, or NAD, operates within the independent nonprofit organization BBB National Programs. The source describes voluntary industry-funded self-regulation supplementing government oversight, rather than replacing public enforcement. Advertisers can challenge another company’s claim, and competitors frequently bring such substantiation disputes. Current NAD procedures also accept consumers and organizations, while the program monitors advertising itself. It reviews national advertising claims and evidence supporting their actual meaning. Its conclusions recommend modifying or discontinuing claims. They do not constitute NAD’s own legally binding court injunction. The process offers structured filing tracks intended to resolve disputes efficiently as an alternative to litigation. Actual time and expense depend on the dispute, so faster and cheaper are not universal guarantees. An advertiser may decline participation or compliance, but voluntariness does not prevent a referral. NAD can refer such matters to FTC or another appropriate regulator for possible enforcement action. The regulator then evaluates its own authority, evidence, and enforcement decision rather than automatically prosecuting. Neither an adverse recommendation nor a favorable self-review determination independently settles government liability or immunity.
The Full Weight-Loss Example: Claim and Evidence
The Competitor Challenges a Precise Clinical Promise; the Cited Study Cannot Support It
The example concerns a hypothetical supplement company making a precise weight-loss promise. It advertises the product as clinically proven to reduce belly fat by thirty percent. A skeptical competitor chooses a NAD challenge rather than initially going to court or a regulator. The percentage communicates a measurable benefit. The clinical-proof language communicates particular evidentiary support as well. NAD finds the cited study too small and methodologically weak for that specific figure. Both weaknesses are supplied by the source, but no particular sample size or method is identified. The recommendation is to provide stronger substantiation or discontinue the unsupported advertising claim. Adequate evidence must exist before any continued or renewed objective promise is disseminated to consumers. The recommendation does not permit continued advertising while a company searches for better research. The source identifies no actual product, brand, trial, jurisdiction, or dated NAD decision for this example. It illustrates matching evidentiary strength to the actual percentage and proof language communicated by an advertisement. An impressive scientific label cannot substitute for relevant, adequate support for the claim itself.
The Full Weight-Loss Example: Partial Change and Referral
Changing One Version Does Not Resolve the Unsupported Claim Still Running Elsewhere
The company modifies its advertising language, but that partial response does not end the source example. It continues running a version of the claim in another market without the required substantiation. NAD then refers the matter to FTC, and the hypothetical says FTC opens its own investigation. Moving the message to a different market does not resolve its missing evidentiary basis. Changing one version also does not establish that all continuing versions now have adequate support. The self-regulatory process has created a documented record of the claim and the evidence problem. That record can help the government evaluate the matter and develop a case independently. It does not compel FTC to adopt NAD’s conclusions or automatically find a violation. An investigation examines allegations and evidence. It is not itself a final judgment establishing liability. The source gives no eventual injunction, fine, penalty amount, or other completed enforcement outcome. Preserve the escalation without inventing a real-world decision or treating referral as an automatic sanction. This illustrates how voluntary review may inform formal enforcement while leaving the government’s legal assessment independent.
All Five Terms and Five Takeaways
Keep Misleading Meaning, Prior Evidence, Subjective Praise, Civil Suit, and Self-Regulation Distinct
The source defines five terms that organize the lesson’s distinct forms of advertising accountability. Deceptive advertising involves likely misleading material meaning, viewed through a reasonable consumer in the circumstances. Prior substantiation requires a reasonable evidentiary basis for an objective claim before it is made. Puffery describes subjective or exaggerated praise not reasonably understood as a factual representation in context. The Lanham Act supplies a federal private civil route for qualifying commercial false-advertising injury. NAD is the voluntary National Advertising Division within BBB National Programs, reviewing claims and recommending changes. The first takeaway connects FTC’s deception standard with evidence that must precede objective claims. The second distinguishes subjective puffery from specific, testable promises requiring adequate support before publication. The third preserves direct business litigation, qualified by the statute’s plaintiff and causation requirements. The fourth preserves voluntary industry review and referral when the self-regulatory process cannot secure compliance. The fifth connects that review to government escalation in the complete weight-loss teaching example. The channels can coexist or occur in another order; the example mandates no universal sequence.
All Five Review Questions and Model Answers
Explain the Legal Test, Two Claims, Private Enforcement, Incomplete Compliance, and Prior Proof
First, explain deception using likely misleading meaning to a reasonable consumer and material product-related decisions or conduct. The source’s purchasing example is included, but materiality extends beyond the purchase decision alone. Second, compare subjective best-tasting coffee praise with the precise forty percent clinical cavity-reduction promise. The former illustrates puffery; the latter needs evidence supporting both the benefit and clinical-proof wording. Third, distinguish a qualifying business’s private Lanham Act lawsuit from government enforcement brought by FTC. Commercial injury and proximate cause matter, and the plaintiff need not always be a direct competitor. Fourth, explain why the source’s NAD review did not fully resolve the supplement dispute. The company changed one advertisement but continued an unsupported version elsewhere, prompting referral and investigation. NAD’s recommendation did not become its own court order, nor did referral automatically establish final liability. Fifth, explain what prior substantiation adds: the adequate evidentiary basis must exist before dissemination. Later evidence does not authorize advertising first and waiting for a challenge before developing support. Responsible advertising matches the actual message with adequate prior evidence and recognizes these independent accountability channels.
About Business Ethics at UPI Study
Business Ethics (Business 211) is a self-paced online course of 105 video lessons in 19 chapters, from moral reasoning and compliance to governance, diversity, government and society, social responsibility, consumers, advertising, technology, the environment and global business. It carries a NCCRS credit recommendation for 3 semester credits.
Every lesson transcript is free on pages like this one, and the videos are free with a free UPI Study account. Enrolling adds a practice quiz after each lesson, the graded work and final exam that earn the credit, lifetime access, and an official transcript on completion. UPI Study has helped over 130,000 students with college credits. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Enroll now → Course details Download the syllabus All Business courses Every course with PRO →
Compare: Which ethics course? · Business Law vs Business Ethics
Why take it here
Why students take Business Ethics with UPI Study
Where the credit goes
Universities that work with NCCRS
Business Ethics carries a NCCRS credit recommendation. These universities work with NCCRS; some are UPI Study's signed partners. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Thomas Edison State UniversitySigned partner
University of the PeopleSigned partner
Charter Oak State CollegeSigned partner
Strayer UniversitySigned partner
Columbia Southern UniversitySigned partner
Indiana TechSigned partner
Penn StateWorks with NCCRS
Southern New Hampshire UniversityWorks with NCCRS
SUNYWorks with NCCRS
+many more cooperating universitiesFind my college →Find my college → Not listed? Ask Athena in the corner of this page, or book a 15-minute call.
FAQ
Questions students ask us
About How Advertising Is Regulated: Laws, Agencies, and Industry Self-Governance
What is the FTC's standard for deceptive advertising?
What is prior substantiation in advertising?
Can a company sue another company for false advertising?
What does the National Advertising Division do?
About the Business Ethics course
How many college credits is Business Ethics?
How much does Business Ethics cost and what is included?
Which universities accept UPI Study credits?
How long does Business Ethics take?
How are the exams done?
How do my credits reach my college?
Ready for the full course? Earn 3 credits in Business Ethics.
105 video lessons, a quiz after each one, and the graded work that earns the credit. Recommended for credit by NCCRS.
3 credits · NCCRSEnroll →